Concept:
The biological characteristics and decay kinetics (half-lives) of serum tumor markers (AFP and HCG) are foundational to the diagnosis, staging, and post-operative monitoring of testicular cancer.
Explanation:
• Option A: It is an absolute clinical rule that pure seminomas do not possess the cellular machinery to produce Alpha-Fetoprotein (AFP). If a patient's pathology report reads "pure seminoma" but their serum AFP is elevated, the tumor must clinically be treated as a Non-Seminomatous Germ Cell Tumor (NSGCT). The elevated AFP implies the presence of occult yolk sac or embryonal elements that the pathologist missed.
• Options B & C: The serum half-lives given in the options are swapped. The normal serum half-life of Human Chorionic Gonadotropin (HCG) is short, approximately 24 to 36 hours (1-1.5 days). The normal serum half-life of AFP is much longer, approximately 5 to 7 days. Knowing these kinetics is vital to determine if a patient is responding to orchiectomy or if occult disease remains.
• Option D: According to the International Germ Cell Cancer Collaborative Group (IGCCCG) risk classification for NSGCTs, tumor marker levels dictate prognosis. An HCG level of $<$ 5,000 mIU/mL actually places the patient in the "Good Prognosis" category. A "Poor Prognosis" designation requires massively elevated markers, such as an HCG $>$ 50,000 mIU/mL or AFP $>$ 10,000 ng/mL.
Final Answer:
The only true statement is that pure seminomas never produce AFP, a critical fact that alters clinical management if an elevation is detected.